Soins intégrés BPCO (Broncho-pneumopathie Chronique Obstructive) en Valais - Mieux Vivre Avec ma BPCO (COPD Integrated Care Program Valais - Living Well With COPD)
Launched by CENTRE HOSPITALIER DU CENTRE DU VALAIS · Nov 29, 2013
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
Background: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by acute exacerbations that contribute to physical impairment and increased healthcare use and costs. Given the increasing burden of this disease in terms of morbidity, disability, mortality and costs, innovative care models centered on patients and aiming at improving quality and comprehensiveness of care are needed. Effective implementation and evaluation of chronic disease management - integrated care(CDM-IC) programs, in the real world context is of great importance.
Aim of the ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of COPD (GOLD stage 1-symptomatic to 4)
- • Age \>= 35 years
- • Residing in the canton of Valais Switzerland, non-institutionalized
- • Informed consent
- Exclusion Criteria:
- • Hospitalization during previous 4 weeks
- • Pulmonary rehabilitation during past 18 months
- • Estimated life expectancy \< 12 months
- • Obvious cognitive impairment
- • Not speaking or understanding French well enough
About Centre Hospitalier Du Centre Du Valais
Centre Hospitalier du Centre du Valais (CHCV) is a leading healthcare institution located in the Valais region of Switzerland, dedicated to providing high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, CHCV focuses on innovative healthcare solutions and collaborates with various stakeholders to facilitate cutting-edge clinical studies. The institution is committed to enhancing patient outcomes through rigorous scientific inquiry and adherence to ethical standards, fostering a collaborative environment that supports the development of new therapies and treatments. With a multidisciplinary team of experienced professionals, CHCV plays a pivotal role in contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Crans Montana, Valais, Switzerland
Patients applied
Trial Officials
Isabelle Peytremann-Bridevaux, MD, MPH, DSc
Principal Investigator
University of Lausanne Hospitals
Bernard Burnand, MD, MPH
Principal Investigator
University of Lausanne Hospitals
Jean-Marie Tschopp, MD
Principal Investigator
Centre Hospitalier du Centre du Valais
Pierre-Olivier Bridevaux, MD, MSc
Principal Investigator
Centre Hospitalier du Centre du Valais
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials